Am­gen con­tin­ues to tar­get mid-De­cem­ber dead­line for Hori­zon deal close

Am­gen and Hori­zon con­tin­ue to tar­get a mid-De­cem­ber close for their $28 bil­lion merg­er, though a court or­der tem­porar­i­ly block­ing the deal has been ex­tend­ed now that a hear­ing date has been set.

A tem­po­rary re­strain­ing or­der pre­vent­ing the com­pa­nies from clos­ing the deal has been ex­tend­ed to Oct. 31, ac­cord­ing to a se­cu­ri­ties fil­ing post­ed Fri­day. The dead­line was pre­vi­ous­ly Sept. 15, but was ex­tend­ed more than a month “based on the court’s sched­ule,” Am­gen said, adding that an ev­i­den­tiary hear­ing on the Fed­er­al Trade Com­mis­sion’s chal­lenge has been set for Sept. 11.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER